MessageCompany OverviewCorporate PhilosophyHistoryNews ReleaseMap


May 1998 ReqMed was founded by Kyowa Hakko Kogyo Co., Ltd. and Tadashi Matsumoto to facilitate pharmaceutical companies in creating strategic alliances with innovative bio-pharmaceutical companies
Jun 1999 ReqMed became independent from Kyowa Hakko Kogyo Co., Ltd.
Feb 2000 Life Science Venture Fund (LSVF I) , an investment fund specializing in the biotechnology field that was the first of its kind in Japan, was created
Nov 2000 ReqMed Research, Inc. was founded in South San Francisco to facilitate partnerships between US and Japanese firms
Nov 2001 ReqMed raised 150 million yen through its first Private equity financing
Aug 2003 ReqMed raised 200 million yen for our collaborative "Drug Development Project" through its second Private equity financing
Sep 2003 ReqMed Venture Capital (RMVC) was established to separate the investment business from the consulting business
Feb 2004 Life Science Venture Fund II (LSVF II) was founded by RMVC and mblVC
Apr 2004 ReqMed announced a strategic alliance with CMIC Co., Ltd., the largest CRO in Japan
Feb 2006 ReqMed raised 707 million yen for our collaborative "Drug Development Project" through its third private equity fancing
Jan 2007 Phase I study of NaPPS(pentosan) commenced by owned sponsorship
Jun 2008 License Agreement with Asahi Kasei Pharma Corporation in partnership with bene pharmaChem GmbH & Co.KG for the development of NaPPS in Japan
Mar 2009 Initiated Phase I PK study of eltoprazine in US
Apr 2010 Initiated Phase IIa study of pentosan in Japan by Asahi Kasei Pharma

Copyright (C) 2008 ReqMed Company, Ltd. All Rights Reserved.